Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Global Blood Therapeutics, Inc. (GBT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2022 4 PERRY MARK L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 37,865 shares @ $0
Disposed/sold 3,600 restricted stock units @ $0
Disposed/sold 15,000 options to buy @ $42.25, valued at $633.8k
Disposed/sold 7,500 options to buy @ $56.3, valued at $422.3k
Disposed/sold 5,247 options to buy @ $64.75, valued at $339.7k
Disposed/sold 5,600 options to buy @ $37.09, valued at $207.7k
Disposed/sold 5,600 options to buy @ $22.3, valued at $124.9k
10/06/2022 4 PATRICK DEVAL L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 9,037 shares @ $0
Disposed/sold 3,600 restricted stock units @ $0
Disposed/sold 625 options to buy @ $68.75, valued at $43k
Disposed/sold 5,247 options to buy @ $64.75, valued at $339.7k
Disposed/sold 5,600 options to buy @ $37.09, valued at $207.7k
Disposed/sold 5,600 options to buy @ $22.3, valued at $124.9k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 YARNO WENDY L (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 11,437 shares @ $0
Disposed/sold 3,600 restricted stock units @ $0
Disposed/sold 30,000 options to buy @ $38.55, valued at $1.2M
Disposed/sold 15,000 options to buy @ $42.25, valued at $633.8k
Disposed/sold 7,500 options to buy @ $56.3, valued at $422.3k
Disposed/sold 5,247 options to buy @ $64.75, valued at $339.7k
Disposed/sold 5,600 options to buy @ $37.09, valued at $207.7k
Disposed/sold 5,600 options to buy @ $22.3, valued at $124.9k
10/06/2022 4 Pizzo Philip A. (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 9,112 shares @ $0
Disposed/sold 3,600 restricted stock units @ $0
Disposed/sold 15,000 options to buy @ $42.25, valued at $633.8k
Disposed/sold 7,500 options to buy @ $56.3, valued at $422.3k
Disposed/sold 5,247 options to buy @ $64.75, valued at $339.7k
Disposed/sold 5,600 options to buy @ $37.09, valued at $207.7k
Disposed/sold 5,600 options to buy @ $22.3, valued at $124.9k
Disposed/sold 30,000 options to buy @ $46.49, valued at $1.4M
10/06/2022 4 Svoronos Dawn (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 5,376 shares @ $0
Disposed/sold 3,600 restricted stock units @ $0
Disposed/sold 30,000 options to buy @ $38.68, valued at $1.2M
Disposed/sold 7,500 options to buy @ $56.3, valued at $422.3k
Disposed/sold 5,247 options to buy @ $64.75, valued at $339.7k
Disposed/sold 5,600 options to buy @ $37.09, valued at $207.7k
Disposed/sold 5,600 options to buy @ $22.3, valued at $124.9k
10/06/2022 4 PIERCE GLENN (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 26,437 shares @ $0
Disposed/sold 3,600 restricted stock units @ $0
Disposed/sold 15,000 options to buy @ $15.03, valued at $225.5k
Disposed/sold 15,000 options to buy @ $18.85, valued at $282.8k
Disposed/sold 15,000 options to buy @ $28.45, valued at $426.8k
Disposed/sold 15,000 options to buy @ $42.25, valued at $633.8k
Disposed/sold 7,500 options to buy @ $56.3, valued at $422.3k
Disposed/sold 5,247 options to buy @ $64.75, valued at $339.7k
Disposed/sold 5,600 options to buy @ $37.09, valued at $207.7k
Disposed/sold 5,600 options to buy @ $22.3, valued at $124.9k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 576,318 shares @ $0
Disposed/sold 119,650 shares @ $0
Disposed/sold 102,000 shares @ $0
Disposed/sold 2,500 shares @ $0
Disposed/sold 11,250 restricted stock units @ $0
Disposed/sold 26,865 restricted stock units @ $0
Disposed/sold 47,223 restricted stock units @ $0
Disposed/sold 63,768 restricted stock units @ $0
Disposed/sold 109,116 restricted stock units @ $0
Disposed/sold 141,400 restricted stock units @ $0
Disposed/sold 114,515 options to buy @ $16.4, valued at $1.9M
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 26,739 shares @ $0
Disposed/sold 3,125 restricted stock units @ $0
Disposed/sold 9,060 restricted stock units @ $0
Disposed/sold 13,814 restricted stock units @ $0
Disposed/sold 15,460 restricted stock units @ $0
Disposed/sold 26,454 restricted stock units @ $0
Disposed/sold 42,400 restricted stock units @ $0
Disposed/sold 120,000 options to buy @ $14.96, valued at $1.8M
Disposed/sold 10,299 options to buy @ $16.4, valued at $168.9k
Disposed/sold 35,000 options to buy @ $59.6, valued at $2.1M
Disposed/sold 40,000 options to buy @ $48.44, valued at $1.9M
10/06/2022 4 SUVARI TRICIA BORGA (Chief Legal Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Disposed/sold 43,077 shares @ $0
Disposed/sold 3,125 restricted stock units @ $0
Disposed/sold 9,060 restricted stock units @ $0
Disposed/sold 13,814 restricted stock units @ $0
Disposed/sold 15,460 restricted stock units @ $0
Disposed/sold 26,454 restricted stock units @ $0
Disposed/sold 42,400 restricted stock units @ $0
Disposed/sold 100,000 options to buy @ $18.25, valued at $1.8M
Disposed/sold 40,000 options to buy @ $59.6, valued at $2.4M
Disposed/sold 40,000 options to buy @ $48.44, valued at $1.9M
Disposed/sold 38,500 options to buy @ $65.82, valued at $2.5M
10/04/2022 4 Habibizad Nazila (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Gifted 3,500 shares @ $0
Exercised 1,375 restricted stock units @ $0
Exercised 182 restricted stock units @ $0
09/29/2022 4 Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Exercised 23,653 options to buy @ $16.4, valued at $387.9k
09/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2022 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Gifted 221,200 shares @ $0
Gifted 35,300 shares @ $0
Gifted 17,650 shares @ $0
Exercised 18,291 options to buy @ $16.4, valued at $300k
09/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2022 4 Habibizad Nazila (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 414 shares @ $25.37, valued at $10.5k
Paid exercise price by delivering 1,342 shares @ $68.15, valued at $91.5k
Exercised 1,670 restricted stock units @ $0
Exercised 2,208 restricted stock units @ $0
09/06/2022 4 JOHNSON DAVID LEE (Chief Commercial Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 365 shares @ $25.37, valued at $9.3k
Paid exercise price by delivering 2,103 shares @ $68.15, valued at $143.3k
Exercised 2,763 restricted stock units @ $0
Exercised 2,208 restricted stock units @ $0
09/06/2022 4 Smith-Whitley Kim (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 607 shares @ $68.15, valued at $41.4k
Exercised 2,208 restricted stock units @ $0
09/06/2022 4 Krehlik Carrie (Chief Human Resources Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 3,552 shares @ $68.15, valued at $242.1k
Exercised 8,060 restricted stock units @ $0
Exercised 2,208 restricted stock units @ $0
09/06/2022 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 9,200 shares @ $68.15, valued at $627k
Exercised 9,444 restricted stock units @ $0
Exercised 9,109 restricted stock units @ $0
09/06/2022 4 Farrow Jeffrey S (CFO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,885 shares @ $68.15, valued at $128.5k
Sold 31,441 shares @ $68, valued at $2.1M
Exercised 2,763 restricted stock units @ $0
Exercised 2,208 restricted stock units @ $0
09/06/2022 4 Choi Jung (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,861 shares @ $68.15, valued at $126.8k
Exercised 2,763 restricted stock units @ $0
Exercised 2,208 restricted stock units @ $0
09/06/2022 4 SUVARI TRICIA BORGA (Chief Legal Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Granted 385 shares @ $25.37, valued at $9.8k
Paid exercise price by delivering 1,881 shares @ $68.15, valued at $128.2k
Exercised 2,763 restricted stock units @ $0
Exercised 2,208 restricted stock units @ $0
08/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2022 4 SUVARI TRICIA BORGA (Chief Legal Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,126 shares @ $32.4, valued at $68.9k
Exercised 3,125 restricted stock units @ $0
Exercised 3,020 restricted stock units @ $0
08/03/2022 4 Habibizad Nazila (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 526 shares @ $32.4, valued at $17k
Exercised 937 restricted stock units @ $0
Exercised 581 restricted stock units @ $0
08/03/2022 4 LOVE TED W (President and CEO) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 10,018 shares @ $32.4, valued at $324.6k
Exercised 11,250 restricted stock units @ $0
Exercised 8,955 restricted stock units @ $0
08/03/2022 4 Choi Jung (See Remarks) has filed a Form 4 on Global Blood Therapeutics, Inc.
Txns: Paid exercise price by delivering 2,126 shares @ $32.4, valued at $68.9k
Exercised 3,125 restricted stock units @ $0
Exercised 3,020 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy